Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:40pm, Tuesday, 03'rd Sep 2024
SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small mol
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Tuesday, 03'rd Sep 2024
CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ther
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:16pm, Tuesday, 03'rd Sep 2024
CAMBRIDGE, Mass. , Sept. 3, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, gra
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 03'rd Sep 2024
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on August 30, 2024,
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 03'rd Sep 2024
NEWTON, Mass. , Sept. 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 03'rd Sep 2024
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective o
Trump Media stock slides under $18, a new low since it began publicly trading
02:00pm, Tuesday, 03'rd Sep 2024
Trump Media, the parent company of Truth Social owned by Donald Trump, fell to a new public trading low since it debuted on the Nasdaq stock exchange in March. The DJT dip followed a broader market de
Time To Exchange Nasdaq Stock After Its 23% Gains This Year?
08:45am, Tuesday, 03'rd Sep 2024
NASDAQ stock (NASDAQ: NDAQ) has gained 23% YTD as compared to a 17% rise in the S&P500 index. In sharp contrast, Nasdaq's peer CME Group (NASDAQ: CME) is up 5% YTD.
Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million. Industry-Leading Platform: Aspire is focused on developing a
OTC Markets Group Announces Incorporation of EDGAR® Online Financial Data onto Nasdaq Data Link®
07:00am, Tuesday, 03'rd Sep 2024
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for over 12,000 U.S. and global securities, today announced that EDGAR Onli
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Monday, 02'nd Sep 2024
CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awa
History Says the Nasdaq Will Soar: 2 Growth Stocks to Buy Now, According to Wall Street
04:15am, Saturday, 31'st Aug 2024
The Nasdaq entered a correction in early August, but the index usually recovers quickly. Alphabet is the largest digital advertiser and the third-largest public cloud in the world.
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05:44pm, Friday, 30'th Aug 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Aquaron Acquisition Corp. Announces Receipt of Delisting Notification from Nasdaq
05:00pm, Friday, 30'th Aug 2024
NEW YORK , Aug. 30, 2024 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the "Company"), a special purpose acquisition company, announced today that it received a written notice (the "Letter")
BurgerFi Receives Nasdaq Deficiency Notices
04:30pm, Friday, 30'th Aug 2024
FORT LAUDERDALE, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of the high-quality, casual dining pizza brand A
